Navigation Links
Kendle to Present at the 29th Annual Raymond James Institutional Investors Conference

CINCINNATI, Feb. 29 /PRNewswire-FirstCall/ -- Kendle (Nasdaq: KNDL), a leading, global full-service clinical research organization, today announced that Vice President and Chief Marketing Officer Simon Higginbotham will participate in the 29th Annual Raymond James Institutional Investors Conference. The conference will be held at the Hyatt Regency Grand Cypress in Orlando, March 2-5, 2008. Kendle's presentation is scheduled for Wednesday, March 5 at 1:40 p.m. Eastern Time.

(Logo: )

The public is invited to listen to a live webcast of Kendle's presentation at (click on the link provided in the Investor Events section) or at An archived version can be accessed following Kendle's presentation and will be available through April 4. Slides accompanying the presentation will be available by 9 a.m. Eastern Time on March 5 at in the Investor Relations section.

About Kendle

Kendle International Inc. (Nasdaq: KNDL) is among the world's leading global clinical research organizations. We deliver innovative and robust clinical development solutions -- from first-in-human studies through market launch and surveillance -- to help the world's biopharmaceutical companies maximize product life cycles and grow market share.

Our global clinical development business is focused on five regions -- North America, Europe, Asia/Pacific, Latin America and Africa -- to meet customer needs. We have conducted clinical trials and provided regulatory and pharmacovigilance services in more than 80 countries. Kendle was named "Top CRO to Work With" in the Thomson CenterWatch 2007 survey of U.S. investigative sites and "Best CRO" for 2007 and 2006 by leading global pharmaceutical publication Scrip.

Additional information and investor kits are available upon request from Kendle, 441 Vine Street, Suite 1200, Cincinnati, OH 45202 or from the Company's Web site at

SOURCE Kendle International Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Kendle Hires Satish Tripathi, PhD, RAC as Vice President, Global Regulatory and Quality
2. Kendle to Present at the Wachovia 2008 Healthcare Conference
3. Kendle Appoints Former MHRA Head of Biologics as Principal Regulatory Affairs Consultant
4. Kendle Named Best CRO for Second Consecutive Year by Leading Global Pharmaceutical Publication Scrip
5. Kendle Invites You to Attend Its Third Quarter 2007 Earnings Conference Call and Webcast
6. Kendle to Present at the Natixis Bleichroeder Hidden Gems Conference
7. Kendle to Present at the UBS Global Life Sciences Conference
8. Kendle to Present at Bear Stearns 20th Annual Healthcare Conference
9. Kendle to Present at Thomas Weisel Partners Healthcare Conference 2007
10. Kendle Marks 10th Anniversary as Public Company With NASDAQ Opening Bell Ceremony and Investor Day Event
11. Kendle to Ring Opening Bell at NASDAQ Stock Market on August 22
Post Your Comments:
(Date:10/13/2015)... ... 2015 , ... The Pistoia Alliance has appointed Dr Steve ... drive to increase the organization’s impact on the global innovation landscape in life ... its work in supporting pre-competitive collaboration in the life sciences sector. Steve brings ...
(Date:10/13/2015)... Applied BioMath ( ), a computational ... the drug invention process, announced that it will sponsor ... 20-22, 2015 in Boston , MA.  ... CEO of Applied BioMath, will present "QSP approaches enabling quantitative ... trials" on Wednesday October 21st 2015 at 12:30PM.  ...
(Date:10/13/2015)... ARRY ), Avanex Life Sciences ... ), and Progenix Pharmaceuticals, Inc. (NASDAQ: PGNX ) ... (OTCQX: AVXLD), Juno Therapeutics, Inc. (NASDAQ: JUNO ), ... --> Cooperative research and development efforts with the ... to advancements in the treatment of severe wounds.  Biotech ...
(Date:10/13/2015)... and SAN DIEGO , ... Mast Therapeutics, Inc. have agreed to collaborate in the ... poloxamer 188 NF, marketed by BASF under the Kolliphor ... a variety of pharmaceutical and biological applications, such as ... is the starting material for Mast,s lead product candidate. ...
Breaking Biology Technology:
(Date:10/2/2015)... 2015 ) ... the Law Using Biometrics" report to their ... the addition of the "Enforcing the Law ... --> Research and Markets ( ) ... the Law Using Biometrics" report to their ...
(Date:9/30/2015)... Sept. 30, 2015  The global glucose monitoring device and ... So says a new report on the industry from Kalorama ... dominate the market, followed by continuous glucose monitoring and sensor ... the market for these products in its latest report, ... , ...
(Date:9/28/2015)... 28, 2015  The monitoring of vital signs, ... temperature, is an essential component of patient assessment. ... deterioration in a patient,s condition. However, in general ... typically taken during routine observation rounds only once ... deteriorates between these observation rounds, the warning signs ...
Breaking Biology News(10 mins):